{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:38:41Z","timestamp":1782491921217,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002457","name":"Chosun University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbrc.2024.151216","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:46:56Z","timestamp":1734680816000},"page":"151216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Therapeutic potential of the flavonoid compound Licochalcone D in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"744","author":[{"given":"Nagarajan","family":"Maharajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan A.","family":"Vijayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang-Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.151216_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.151216_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.151216_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrc.2024.151216_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2024.151216_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2024.151216_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.151216_bib7","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbrc.2024.151216_bib8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/acel.12446","article-title":"AMPK activation protects cells from oxidative stress-induced senescence via autophagic flux restoration and intracellular NAD(+) elevation","volume":"15","author":"Han","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbrc.2024.151216_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/js.2017-00092","article-title":"Targeting NAD+ in metabolic disease: New insights into an old molecule","volume":"1","author":"Elhassan","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.bbrc.2024.151216_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Cant\u00f3","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.151216_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.151216_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.cmet.2014.06.001","article-title":"SnapShot: sirtuins, NAD, and aging","volume":"20","author":"Nakagawa","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2024.151216_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1080\/10408398.2014.952399","article-title":"The potential of flavonoids in the treatment of metabolic dysfunction-associated steatotic liver disease","volume":"57","author":"Van De Wier","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bbrc.2024.151216_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030530","article-title":"In vivo rodent models of type 2 diabetes and their usefulness for evaluating flavonoid bioactivity","volume":"11","author":"Fang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.bbrc.2024.151216_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00253-011-3449-2","article-title":"Metabolic engineering of flavonoids in plants and microorganisms","volume":"91","author":"Wang","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrc.2024.151216_bib16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1017\/S0007114520002846","article-title":"Higher flavonoid intake is associated with a lower progression risk of metabolic dysfunction-associated steatotic liver disease in adults: a prospective study","volume":"125","author":"Zhong","year":"2021","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbrc.2024.151216_bib17","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1248\/cpb.37.2528","article-title":"Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin","volume":"37","author":"Okada","year":"1989","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.bbrc.2024.151216_bib18","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/0031-9422(92)83481-D","article-title":"Two prenylated retrochalcones from Glycyrrhiza inflata","volume":"31","author":"Kajiyama","year":"1992","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbrc.2024.151216_bib19","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.3390\/ijms22147324","article-title":"Licochalcone D ameliorates oxidative stress-induced senescence via AMPK activation","volume":"22","author":"Maharajan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.151216_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050447","article-title":"Protective effects of Licochalcone A ameliorates obesity and metabolic dysfunction-associated steatotic liver disease via promotion of the sirt-1\/AMPK pathway in mice fed a high-fat diet","volume":"8","author":"Liou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2024.151216_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.560905","article-title":"Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151216_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13578-020-00477-1","article-title":"Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1\/AMPK signaling in obese mice","volume":"10","author":"Liou","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbrc.2024.151216_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2017.0039","article-title":"Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis","volume":"24","author":"Dhami-Shah","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.bbrc.2024.151216_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrc.2024.151216_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.151216_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113473","article-title":"Involvement of 5'-activated protein kinase (AMPK) in the effects of resveratrol on liver steatosis","volume":"19","author":"Trepiana","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2024.151216_bib27","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.3748\/wjg.v25.i45.6607","article-title":"LB100 ameliorates nonalcoholic fatty liver disease via the AMPK\/Sirt1 pathway","volume":"25","author":"Chen","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2024.151216_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2010.09.014","article-title":"Regulation of hepatic metabolism by AMPK","volume":"54","author":"Foretz","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2024.151216_bib29","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/bph.13855","article-title":"Natural alkaloid bouchardatine ameliorates metabolic disorders in high-fat diet-fed mice by stimulating the sirtuin 1\/liver kinase B-1\/AMPK axis","volume":"174","author":"Rao","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151216_bib30","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1039\/D0FO02501A","article-title":"Berbamine induced activation of the SIRT1\/LKB1\/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats","volume":"12","author":"Sharma","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.bbrc.2024.151216_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.151216_bib32","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151216_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0896(97)10034-7","article-title":"Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata","volume":"6","author":"Haraguchi","year":"1998","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.151216_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.intimp.2009.01.031","article-title":"Glycyrrhiza inflata-derived chalcones, Licochalcone A, Licochalcone B and Licochalcone D, inhibit phosphorylation of NF-kappaB p65 in LPS signaling pathway","volume":"9","author":"Furusawa","year":"2009","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.bbrc.2024.151216_bib35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2024.151216_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A population-based study on the prevalence of NASH using scores validated against liver histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2024.151216_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","article-title":"AMP\u2010activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives","volume":"196","author":"Viollet","year":"2009","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bbrc.2024.151216_bib39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.bbrc.2024.151216_bib40","article-title":"Streptozotocin-induced diabetic models in mice and rats","volume":"70","author":"Furman","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151216_bib41","article-title":"Gallic acid ameliorated impaired lipid homeostasis in a mouse model of high-fat diet-and streptozotocin-induced NAFLD and diabetes through improvement of \u03b2-oxidation and ketogenesis","volume":"11","author":"Chao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.151216_bib43","article-title":"Pentoxifylline ameliorates metabolic dysfunction-associated steatotic liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid \u03b2-oxidation","volume":"6","author":"Ye","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24017522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24017522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T15:59:37Z","timestamp":1735660777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24017522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"alternative-id":["S0006291X24017522"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151216","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of the flavonoid compound Licochalcone D in metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.151216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151216"}}